Skip to main content
Premium Trial:

Request an Annual Quote

Transinsight Partners with Max Planck on Biomedical Image Searching

NEW YORK (GenomeWeb News) - Transinsight, a bioinformatics startup based in Dresden, Germany, said last week that it has entered a three-year collaboration with the Max Planck Institute of Molecular Cell Biology and Genetics in the area of biomedical image analysis.
 
Transinsight said that it plans to extend its GoPubMed search engine “towards biomedical image search and knowledge-based image recognition.” The company said that it plans to focus on “particle tracking imagery produced by high-throughput microscopy.”
 
Marino Zerial, MPI-CBG director, said in a statement that “it is essential to be able to extract more information from the new generation of image-based screens.”
 
Transinsight was founded in late 2005. The company has raised seed financing from the German High-Tech Gründer Fonds and an additional undisclosed amount from a private investor.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.